Search tips
Search criteria 


Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
Proc R Soc Med. 1960 November; 53(11): 930–934.
PMCID: PMC1871082

An Experiment with a Psychiatric Night Hospital

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (875K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • BUSCH AK, JOHNSON WC. L.S.D. 25 as an aid in psychotherapy; preliminary report of a new drug. Dis Nerv Syst. 1950 Aug;11(8):241–243. [PubMed]
  • FISCHER R, GEORGI F, WEBER R. Psychophysische Korrelationen. VIII. Modellversuche zum Schizophrenieproblem: Lysergsäurediäthylamid und Mezcalin. Schweiz Med Wochenschr. 1951 Aug 25;81(34):817–contd. [PubMed]
  • FORRER GR, GOLDNER RD. Experimental physiological studies with lysergic acid diethylamide (LSD-25). AMA Arch Neurol Psychiatry. 1951 May;65(5):581–588. [PubMed]
  • FREDERKING W. Intoxicant drugs (mescaline and lysergic acid diethylamide) in psychotherapy. J Nerv Ment Dis. 1955 Mar;121(3):262–266. [PubMed]
  • PARIS R, BEAUQUESNE L. Les dérivés flavoniques. Ann Pharm Fr. 1950 Mar;8(3):228–236. [PubMed]
  • OLTMAN JE, McGARRY JJ, FRIEDMAN S. Parental deprivation and the broken home in dementia praecox and other mental disorders. Am J Psychiatry. 1952 Mar;108(9):685–694. [PubMed]
  • LIDDELL DW, WEIL-MALHERBE H. The effects of methedrine and of lysergic acid diethylamide on mental processes and on the blood adrenaline level. J Neurol Neurosurg Psychiatry. 1953 Feb;16(1):7–13. [PMC free article] [PubMed]
  • MAYER-GROSS W, McADAM W, WALKER JW. Psychological and biochemical effects of lysergic acid diethylamide. Nature. 1951 Nov 10;168(4280):827–828. [PubMed]
  • RINKEL M, DeSHON HJ, HYDE RW, SOLOMON HC. Experimental schizophrenia-like symptoms. Am J Psychiatry. 1952 Feb;108(8):572–578. [PubMed]
  • SANDISON RA, SPENCER AM, WHITELAW JD. The therapeutic value of lysergic acid diethylamide in mental illness. J Ment Sci. 1954 Apr;100(419):491–507. [PubMed]
  • SANDISON RA, WHITELAW JD. Further studies in the therapeutic value of lysergic acid diethylamide in mental illness. J Ment Sci. 1957 Apr;103(431):332–343. [PubMed]
  • SAVAGE C. Lysergic acid diethylamide; a clinical-psychological study. Am J Psychiatry. 1952 Jun;108(12):896–900. [PubMed]
  • SLOANE B, DOUST JW. Psychophysiological investigations in experimental psychoses; results of the exhibition of d-lysergic acid diethylamide to psychiatric patients. J Ment Sci. 1954 Jan;100(418):129–144. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press